A federal appeals court on Friday blocked the mailing of the abortion pill mifepristone, restricting access to one of the most common means of abortion in the U.S. Since the Supreme Court overturned Roe v. Wade in 2022, mail-order prescriptions have become a major way abortions are provided, including in states where bans are in place. The two manufacturers of mifepristone rushed to the Supreme Court on Saturday, asking the justices to immediately block the ruling. In a statement, Planned Parenthood Action Fund President and CEO Alexis McGill Johnson said, “The fight is on, and Planned Parenthood will continue to make clear that mifepristone should be accessible, because it’s safe and effective, full stop.” We’ll have more on this story later in the broadcast.